Ventricular Catheter Systems with Subcutaneous Reservoirs (Ommaya Reservoirs) in Pediatric Patients with Brain Tumors: Infections and Other Complications

Abstract

Objective This study aims to describe complications related to ventricular catheter systems with subcutaneous reservoirs (VCSR) (such as Ommaya reservoirs) in pediatric patients with brain tumors.

Methods Retrospective analysis of consecutive patients with a total of 31 VCSR treated at the Children's University Hospital of Zurich, Switzerland.

Results A total of 20 patients with a median age of 3.3 years at VCSR implantation received 31 VCSR. Overall, 19 complications in 11 patients were recorded: 7 patients had a VCSR-related infection with coagulase-negative staphylococci, 4 of these probably as a surgical complication and 3 probably related to VCSR use. Systemic perioperative prophylaxis was administered in 22 cases, and intraventricular vancomycin and gentamicin were given in 8 cases (none of which subsequently developed an infection). Other complications included wound dehiscence, catheter malplacement, and leakage of cerebrospinal fluid. Overall, 17 VCSR were explanted due to complications.

Conclusion Infections were the most frequent VCSR-related complication. In our own institution, the high rate of complications led to the definition of a bundle of measures as a standard operating procedure for VCSR placement and use. Prospective studies in larger patient collectives are warranted to better identify risk factors and evaluate preventive measures such as the administration of perioperative antibiotics and the use of antimicrobial coating of catheters.

Keywords

Ommaya reservoir - subcutaneous reservoir - ventricular catheter - intraventricular access device - intraventricular chemotherapy - intrathecal chemotherapy - child - brain neoplasms - brain tumors - cancer

• References

• 1 Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004; 5 (7) 399-408
• 2 Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer 2007; 121 (10) 2233-2240
• 3 Gerber NU, Mynarek M, von Hoff K, Friedrich C, Resch A, Rutkowski S. Recent developments and current concepts in medulloblastoma. Cancer Treat Rev 2014; 40 (3) 356-365
• 4 Rutkowski S, Bode U, Deinlein F , et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005; 352 (10) 978-986
• 5 von Bueren AO, von Hoff K, Pietsch T , et al. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro-oncol 2011; 13 (6) 669-679
• 6 Chi SN, Zimmerman MA, Yao X , et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 2009; 27 (3) 385-389
• 7 Blaney SM, Tagen M, Onar-Thomas A , et al. A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study. Pediatr Blood Cancer 2013; 60 (4) 627-632
• 8 Fleischhack G, Reif S, Hasan C, Jaehde U, Hettmer S, Bode U. Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours. Br J Cancer 2001; 84 (11) 1453-1459
• 9 Ommaya AK. Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet 1963; 2 (7315) 983-984
• 10 Shapiro WR, Young DF, Mehta BM. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975; 293 (4) 161-166
• 11 Glantz MJ, Van Horn A, Fisher R, Chamberlain MC. Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis. Cancer 2010; 116 (8) 1947-1952
• 12 Browne MJ, Dinndorf PA, Perek D , et al. Infectious complications of intraventricular reservoirs in cancer patients. Pediatr Infect Dis J 1987; 6 (2) 182-189
• 13 Chamberlain MC, Kormanik PA, Barba D. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 1997; 87 (5) 694-699
• 14 Dinndorf PA, Bleyer WA. Management of infectious complications of intraventricular reservoirs in cancer patients: low incidence and successful treatment without reservoir removal. Cancer Drug Deliv 1987; 4 (2) 105-117
• 15 Kramer K, Smith M, Souweidane MM. Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies. Pediatr Blood Cancer 2014; 61 (9) 1590-1592
• 16 Lishner M, Scheinbaum R, Messner HA. Intrathecal vancomycin in the treatment of Ommaya reservoir infection by Staphylococcus epidermidis. Scand J Infect Dis 1991; 23 (1) 101-104
• 17 Mead PA, Safdieh JE, Nizza P, Tuma S, Sepkowitz KA. Ommaya reservoir infections: a 16-year retrospective analysis. J Infect 2014; 68 (3) 225-230
• 18 Obbens EA, Leavens ME, Beal JW, Lee YY. Ommaya reservoirs in 387 cancer patients: a 15-year experience. Neurology 1985; 35 (9) 1274-1278
• 19 Peyrl A, Chocholous M, Azizi AA , et al. Safety of Ommaya reservoirs in children with brain tumors: a 20-year experience with 5472 intraventricular drug administrations in 98 patients. J Neurooncol 2014; 120 (1) 139-145
• 20 Ratcheson RA, Ommaya AK. Experience with the subcutaneous cerebrospinal-fluid reservoir. Preliminary report of 60 cases. N Engl J Med 1968; 279 (19) 1025-1031
• 21 Sandberg DI, Bilsky MH, Souweidane MM, Bzdil J, Gutin PH. Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 2000; 47 (1) 49-54 , discussion 54–55
• 22 Zairi F, Le Rhun E, Tetard MC, Kotecki N, Assaker R. Complications related to the placement of an intraventricular chemotherapy device. J Neurooncol 2011; 104 (1) 247-252
• 23 Szvalb AD, Raad II, Weinberg JS, Suki D, Mayer R, Viola GM. Ommaya reservoir-related infections: clinical manifestations and treatment outcomes. J Infect 2014; 68 (3) 216-224
• 24 Siegal T, Pfeffer MR, Steiner I. Antibiotic therapy for infected Ommaya reservoir systems. Neurosurgery 1988; 22 (1 Pt 1) 97-100
• 25 Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. Antimicrobial prophylaxis in neurosurgery and after head injury. Lancet 1994; 344 (8936) 1547-1551
• 26 Bratzler DW, Dellinger EP, Olsen KM , et al; American Society of Health-System Pharmacists (ASHP); Infectious Diseases Society of America (IDSA); Surgical Infection Society (SIS); Society for Healthcare Epidemiology of America (SHEA). Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013; 14 (1) 73-156
• 27 Liu W, Ni M, Zhang Y, Groen RJ. Antibiotic prophylaxis in craniotomy: a review. Neurosurg Rev 2014; 37 (3) 407-414 , discussion 414
• 28 Thomas R, Lee S, Patole S, Rao S. Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and meta-analysis. Br J Neurosurg 2012; 26 (2) 175-184
• 29 McCann MT, Gilmore BF, Gorman SP. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J Pharm Pharmacol 2008; 60 (12) 1551-1571
• 30 Mechleb B, Khater F, Eid A, David G, Moorman JP. Late onset Ommaya reservoir infection due to Staphylococcus aureus: case report and review of Ommaya Infections. J Infect 2003; 46 (3) 196-198
• 31 Park DM, DeAngelis LM. Delayed infection of the Ommaya reservoir. Neurology 2002; 59 (6) 956-957
• 32 Takahashi M, Yamada R, Tabei Y, Nakamura O, Shinoura N. Navigation-guided Ommaya reservoir placement: implications for the treatment of leptomeningeal metastases. Minim Invasive Neurosurg 2007; 50 (6) 340-345
• 33 Sampath R, Wadhwa R, Tawfik T, Nanda A, Guthikonda B. Stereotactic placement of ventricular catheters: does it affect proximal malfunction rates?. Stereotact Funct Neurosurg 2012; 90 (2) 97-103